Literature DB >> 17497226

Frequency distribution of the G/A alleles of the beta-fibrinogen gene in the Lebanese population.

Dina M R Shammaa1, Amira S Sabbagh, Ali T Taher, Ghazi S Zaatari, Rami A R Mahfouz.   

Abstract

Fibrinogen is a plasma protein that has been reported to be associated with an increased risk of atherothrombotic diseases and venous thrombosis. The most common polymorphism that has been studied so far in different populations is the G-455-->A polymorphism in the promoter region of the beta-fibrinogen gene. We studied 160 healthy unrelated Lebanese individuals for the prevalence of -455G/G, -455G/A and -455A/A genotypes of the beta-fibrinogen gene and the frequency of G and A alleles using a reverse hybridization PCR assay. The prevalence of the G/G, G/A, and A/A genotypes were found to be 60.6, 31.9 and 7.5%, respectively. The frequency of the G and A alleles were found to be 0.77 and 0.23, respectively. As compared to other ethnic groups, the Lebanese individuals were found to have a relatively high prevalence of the A allele which may predispose them to develop cardiovascular diseases as well as thrombotic events. This study provides additional unique genetic information pertaining to the Lebanese population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17497226     DOI: 10.1007/s11033-007-9087-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  44 in total

1.  High prevalence of Factor V Leiden mutation among healthy individuals and patients with deep venous thrombosis in Lebanon: is the eastern Mediterranean region the area of origin of this mutation?

Authors:  A Taher; I Khalil; A Shamseddine; F El-Ahdab; A Bazarbachi
Journal:  Thromb Haemost       Date:  2001-08       Impact factor: 5.249

2.  Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration.

Authors:  F M van 't Hooft; S J von Bahr; A Silveira; A Iliadou; P Eriksson; A Hamsten
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-12       Impact factor: 8.311

3.  Beta-fibrinogen gene-455 G/A polymorphism and fibrinogen levels. Risk factors for coronary artery disease in subjects with NIDDM.

Authors:  A M Carter; M W Mansfield; M H Stickland; P J Grant
Journal:  Diabetes Care       Date:  1996-11       Impact factor: 19.112

4.  Coagulation gene polymorphisms as risk factors for myocardial infarction in young Indian Asians.

Authors:  R J Pegoraro; N Ranjith; L Rom
Journal:  Cardiovasc J S Afr       Date:  2005 May-Jun

5.  Fibrinogen polymorphisms are not associated with the risk of myocardial infarction.

Authors:  C J Doggen; R M Bertina; V M Cats; F R Rosendaal
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

6.  No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age.

Authors: 
Journal:  Circulation       Date:  2003-03-04       Impact factor: 29.690

7.  Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature.

Authors:  E Ernst; K L Resch
Journal:  Ann Intern Med       Date:  1993-06-15       Impact factor: 25.391

8.  The role of beta-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden.

Authors:  F Green; A Hamsten; M Blombäck; S Humphries
Journal:  Thromb Haemost       Date:  1993-12-20       Impact factor: 5.249

9.  Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde.

Authors:  I Behague; O Poirier; V Nicaud; A Evans; D Arveiler; G Luc; J P Cambou; P Y Scarabin; L Bara; F Green; F Cambien
Journal:  Circulation       Date:  1996-02-01       Impact factor: 29.690

10.  A variant of beta fibrinogen is a genetic risk factor for coronary artery disease and myocardial infarction.

Authors:  Q Yu; F Safavi; R Roberts; A J Marian
Journal:  J Investig Med       Date:  1996-04       Impact factor: 2.895

View more
  3 in total

1.  The association between cardiovascular disease gene mutations and recurrent pregnancy loss in the Lebanese population.

Authors:  Hanadi El Achi; Johnny Awwad; Sarah Abou Daya; Sahar Halabi; Sandra Damianos; Rami Mahfouz
Journal:  Mol Biol Rep       Date:  2018-07-04       Impact factor: 2.316

2.  Significance of the use of the ViennaLab "Cardiovascular Disease panel" (CVD) Assay as a reflex test for the "Factor V/II/MTHFR Assay".

Authors:  Rouba Hoteit; Fatmeh Abbas; Ahmad Antar; Rabab Abdel Khalek; Dina Shammaa; Rami Mahfouz
Journal:  Meta Gene       Date:  2013-11-19

3.  High Incidence of ACE/PAI-1 in Association to a Spectrum of Other Polymorphic Cardiovascular Genes Involving PBMCs Proinflammatory Cytokines in Hypertensive Hypercholesterolemic Patients: Reversibility with a Combination of ACE Inhibitor and Statin.

Authors:  Jeanne d'Arc AlBacha; Mira Khoury; Charbel Mouawad; Katia Haddad; Samar Hamoui; Albert Azar; Ziad Fajloun; Nehman Makdissy
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.